J Ménard

885 total citations
22 papers, 683 citations indexed

About

J Ménard is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J Ménard has authored 22 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J Ménard's work include Blood Pressure and Hypertension Studies (4 papers), Hormonal Regulation and Hypertension (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). J Ménard is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Hormonal Regulation and Hypertension (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). J Ménard collaborates with scholars based in France, Switzerland and United States. J Ménard's co-authors include Gilles Châtellier, Patrice Degoulet, Frédéric Cumin, Éric Zapletal, Christian Schnell, Jeanette M. Wood, Randy L. Webb, Pierre Corvol, J Nussberger and T T Guyene and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J Ménard

19 papers receiving 638 citations

Peers

J Ménard
M. Dominique Ashen United States
Carlos Arauz-Pacheco United States
Annette Bak Netherlands
D. Gordon United Kingdom
Annette Fitz United States
D. M. Burley Switzerland
M. Dominique Ashen United States
J Ménard
Citations per year, relative to J Ménard J Ménard (= 1×) peers M. Dominique Ashen

Countries citing papers authored by J Ménard

Since Specialization
Citations

This map shows the geographic impact of J Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Ménard more than expected).

Fields of papers citing papers by J Ménard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Ménard. The network helps show where J Ménard may publish in the future.

Co-authorship network of co-authors of J Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of J Ménard. A scholar is included among the top collaborators of J Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Ménard. J Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wood, Jeanette M., Christian Schnell, Frédéric Cumin, J Ménard, & Randy L. Webb. (2005). Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. Journal of Hypertension. 23(2). 417–426. 126 indexed citations
2.
Thijs, Lutgarde, Jan A. Staessen, Hilde Celis, et al.. (1999). The International Database of Self-Recorded Blood Pressures in normotensive and untreated hypertensive subjects. Blood Pressure Monitoring. 4(2). 77–86. 49 indexed citations
3.
Châtellier, Gilles, et al.. (1996). The number needed to treat: a clinically useful nomogram in its proper context. BMJ. 312(7028). 426–429. 147 indexed citations
4.
Degoulet, Patrice, et al.. (1995). Use of a standardized personal medical record by patients with hypertension: a randomized controlled prospective trial.. PubMed. 12(1). 31–5. 23 indexed citations
5.
Zanchetti, Alberto, John Chalmers, K Arakawa, et al.. (1993). The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting. Blood Pressure. 2(2). 86–100. 118 indexed citations
6.
Arnal, Jean‐François, et al.. (1993). [Vasodilator effect of nitric oxide is a necessary counter-regulation in the spontaneously hypertensive rat].. PubMed. 86(8). 1193–6. 2 indexed citations
7.
Brunel, Patrick, et al.. (1990). Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.. British Journal of Clinical Pharmacology. 29(5). 503–509. 1 indexed citations
8.
Jeunemaı̂tre, Xavier, J Ménard, J Nussberger, et al.. (1989). Plasma Angiotensins, Renin, and Blood Pressure During Acute Renin Inhibition by CGP 38 560A in Hypertensive Patients. American Journal of Hypertension. 2(11 Pt 1). 819–827. 71 indexed citations
9.
Bouhnik, J, F. X. Galen, J Ménard, et al.. (1987). Production and characterization of human renin antibodies with region-oriented synthetic peptides.. Journal of Biological Chemistry. 262(6). 2913–2918. 18 indexed citations
10.
Corvol, Pierre & J Ménard. (1986). [From the renin gene to renin inhibitors].. PubMed. 47(3). 156–66. 2 indexed citations
11.
Pinet, F, M.T. Corvol, Jean-Pierre Bourguignon, et al.. (1985). Isolation of renin-producing human cells by transfection with three simian virus 40 mutants.. Proceedings of the National Academy of Sciences. 82(24). 8503–8507. 32 indexed citations
12.
Cumin, Frédéric, Geneviève Evin, Jean‐Alain Fehrentz, et al.. (1985). Inhibition of human renin by synthetic peptides derived from its prosegment.. Journal of Biological Chemistry. 260(16). 9154–9157. 50 indexed citations
13.
Sassano, P, et al.. (1984). A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension.. PubMed. 2(2). S75–80. 6 indexed citations
14.
Corvol, Pierre, Jean‐Jacques Panthier, Florent Soubrier, J Ménard, & F Rougeon. (1983). Mouse submaxillary renin: a useful model for the study of renal renin.. PubMed. 1(1). 3–7. 4 indexed citations
15.
Abuaf, N, et al.. (1983). [Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa].. PubMed. 14 Suppl 2. 61–6. 3 indexed citations
16.
Roux, Étienne, et al.. (1980). Effects of selective and nonselective beta adrenergic agents on renin secretion in isolated perfused rat kidney.. Journal of Pharmacology and Experimental Therapeutics. 212(1). 34–38. 17 indexed citations
17.
Corvol, Pierre, et al.. (1977). [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(29). 2569–72. 2 indexed citations
18.
Corvol, Pierre, et al.. (1977). Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(6). 233–5. 1 indexed citations
19.
Corvol, Pierre, et al.. (1977). [Antiandrogenic effect of spirolactones: different mechanisms of action (author's transl)].. PubMed. 37(1). 57–8. 1 indexed citations
20.
Lagrue, G, et al.. (1971). [Cyclic idiopathic edema syndrome. I. Clinical study].. PubMed. 77(12). 929–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026